S Imaging News Today

Initiating treatment within 6 months of the first symptoms of multiple sclerosis is linked to a 45% lower risk for disability years later.

Data from a phase 3 trial suggest high-dose vitamin D does not prevent relapse in patients with RRMS. However, at least one expert suggests the studys exclusion criteria may have been too broad.

New recommendations help clinicians communicate technical information to help patients with multiple sclerosis achieve better understanding and self-care.

The first randomized trial of a disease-modifying therapy in radiological isolated syndrome, the earliest pre-clinical phase of MS, suggests dimethyl fumarate reduced the risk of a first clinical event by 80%.

General neurologists fall short in their knowledge of key multiple sclerosis diagnostic criteria standards compared with MS experts, new findings show, which may be detrimental to patient management.

FORT DODGE, Iowa (AP) — Flipping through the heavy, hard-bound books of mortgage...

High serum levels of neurofilament light are associated with an increased risk for disease progression at 2 years. Clinical, MRI, and OCT measures are not associated with this risk, however.

Twenty-five year data show a positive shift towards earlier diagnosis and treatment of multiple sclerosis and improved prognosis over time.